Shannon N Malabuyo, PA
Physician Assistant · Boise
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · St Lukes Clinic-Treasure Valley LLC · 1,155 clinicians in this group
Looking this up.
Hospitals listed: St Luke'S Nampa Medical Center · St Luke'S Regional Medical Center. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Shannon N Malabuyo’s office to ask if they take your plan before you enroll.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- St Luke'S Nampa Medical CenterNampa, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 81% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.25, Oct 2024 – Sep 2025
- St Luke'S Regional Medical CenterBoise, IDAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Saint Lukes, which runs 9 hospitalsPatients rate it 4 of 5 · 80% would definitely recommend itOverall rating: 5 of 5 starsBetter than the national rate — Clostridium Difficile (C.Diff): 0.459, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.203, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.407, Oct 2024 – Sep 2025Better than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 8.1 (6.8 to 9.7) · 1,092 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for St Luke'S Nampa Medical Center
Behind the star rating — Deaths: 0 better, 6 the same, 0 worse of 6 measures. Safety: 1 better, 4 the same, 0 worse of 5 measures. Readmissions: 0 better, 8 the same, 0 worse of 8 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.25 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.01 (0 to 2.08) · 248 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.02 (0.57 to 1.46) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 8.3 · 27 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 13.2 · 161 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 13.4 · 166 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 7.6 · 149 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.2 · 1,239 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.2 (0 to 0.43) · 1,590 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.47) · 1,581 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.56 (1.07 to 6.05) · 231 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.65 (0 to 3.37) · 42 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.26 (0.55 to 3.97) · 210 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 8.29 (0 to 17.86) · 44 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.01 (0.76 to 9.25) · 30 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.72 (0.21 to 3.24) · 50 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.84 (0 to 1.89) · 1,236 cases | No different | Jul 2022 – Jun 2024 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.6 · 305 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -31.9 · 167 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -26.8 · 176 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15 · 308 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.9 (3.1 to 7.9) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 9.7 (6.4 to 14.7) · 48 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.7 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.4 to 18.8) · 339 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 388 cases | No different | Jan 2024 – Dec 2024 |
What patients said (496 patients answered, 23% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 5 |
| Room was "always" clean | 77% |
| Nurses "always" communicated well | 79% |
| Doctors "always" communicated well | 78% |
| Staff "always" explained | 63% |
| Yes, staff "did" give patients this information | 91% |
| Yes, staff "did" give patients information about help after discharge | 93% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 86% |
| Patients who gave a rating of "9" or "10" (high) | 78% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 73% |
| Nurses "always" listened carefully | 77% |
| Nurses "always" treated them with courtesy and respect | 87% |
| "Always" quiet at night | 63% |
| "YES", patients would definitely recommend the hospital | 81% |
| Staff "always" explained possible side effects | 53% |
| Yes, staff "did" give patients information about possible symptoms | 90% |
See every measure and the patient survey for St Luke'S Regional Medical Center
Behind the star rating — Deaths: 1 better, 6 the same, 1 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 5 better, 6 the same, 0 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Clostridium Difficile (C.Diff)Infections | 0.459 | Better | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.203 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.407 | Better | Oct 2024 – Sep 2025 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 8.1 (6.8 to 9.7) · 1,092 cases | Better | Jan 2024 – Dec 2024 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.61 (0.78 to 2.43) · 2,278 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.84 (0.6 to 1.09) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 139.38 (95.48 to 183.27) · 160 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.7 · 85 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 9.8 · 122 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.8 · 345 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 15 · 508 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.9 · 534 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.4 · 796 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 2.8 · 6,937 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.34 (0.15 to 0.52) · 9,027 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.04 to 0.41) · 9,267 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.48 (1.85 to 5.1) · 2,997 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.33 (0 to 2.7) · 1,577 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.52 (1.25 to 3.8) · 2,793 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.3 (1.86 to 10.74) · 1,482 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.78 (2.15 to 7.42) · 1,483 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.4 (0.03 to 2.76) · 843 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.39 (0 to 0.96) · 7,363 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.7 · 124 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.668 | No different | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.703 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.938 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.1 · 607 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 17.8 · 965 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -3 · 373 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | -48.3 · 559 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -23.7 · 546 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.3 · 901 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (4.1 to 6.4) · 1,092 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.4 · 133 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 9.8 · 131 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.2 · 237 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.6 (10.3 to 18.2) · 361 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.1) · 2,189 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,628 patients answered, 27% of those asked)
| Cleanliness | 4 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 4 |
| Discharge information | 5 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 81% |
| Doctors "always" communicated well | 81% |
| Staff "always" explained | 65% |
| Yes, staff "did" give patients this information | 92% |
| Yes, staff "did" give patients information about help after discharge | 92% |
| Doctors "always" explained things so they could understand | 76% |
| Doctors "always" listened carefully | 80% |
| Doctors "always" treated them with courtesy and respect | 87% |
| Patients who gave a rating of "9" or "10" (high) | 76% |
| Staff "always" explained new medications | 78% |
| Nurses "always" explained things so they could understand | 77% |
| Nurses "always" listened carefully | 78% |
| Nurses "always" treated them with courtesy and respect | 88% |
| "Always" quiet at night | 58% |
| "YES", patients would definitely recommend the hospital | 80% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 91% |
Original Medicare doctor bills
$15,238
Medicare paid this office $15,238 for 171 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 113 | $8,572 | $52 |
| Short return visit (20+ min) | 79 | $3,589 | $36 |
| Long return visit (40+ min) | 27 | $2,331 | $83 |
Who their Medicare patients are
171 Original Medicare patients in 2024. Average age 77 · Women 61% · Also on Medicaid 6% · Health risk score 1.30. At or below the middle of the specialty; the typical physician assistant clinician is at 1.31.
Conditions among them: High blood pressure 75% · Depression 35% · Diabetes 32% · Chronic kidney disease 28% · Atrial fibrillation 20% · Coronary heart disease 19% · Heart failure 16% · Cancer 16% · COPD 16% · Dementia 11% · Stroke 7%.
The office billed $63,149, Medicare allowed $21,841 and paid $15,238; for 312 services of 10 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 171 | 312 | 77 | 1.30 | $63,149 | $15,238 |
| 2023 | 177 | 325 | 77 | 1.23 | $61,903 | $14,373 |
| 2022 | 252 | 402 | 76 | 1.23 | $64,393 | $19,554 |
| 2021 | 264 | 438 | 75 | 1.37 | $63,851 | $22,976 |
| 2020 | 259 | 466 | 76 | 1.49 | $61,246 | $17,762 |
| 2019 | 225 | 319 | 76 | 1.50 | $41,586 | $13,606 |
| 2018 | 51 | 126 | 72 | 0.74 | $11,712 | $5,516 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 3 services
| Return visit (30+ min) | 120 | $8,682 | $47 |
| Short return visit (20+ min) | 80 | $3,394 | $35 |
| Long return visit (40+ min) | 11 | $999 | $77 |
2022: 4 services
| Return visit (30+ min) | 148 | $10,716 | $55 |
| Short return visit (20+ min) | 108 | $4,444 | $38 |
| Long return visit (40+ min) | 23 | $2,021 | $84 |
| Aspiration and/or injection of fluid from large joint | 11 | $421 | $32 |
2021: 5 services
| Return visit (30+ min) | 173 | $12,764 | $55 |
| Short return visit (20+ min) | 96 | $3,645 | $34 |
| Long return visit (40+ min) | 33 | $3,215 | $92 |
| New patient visit (60+ min) | 16 | $1,647 | $103 |
| Aspiration and/or injection of fluid from large joint | 14 | $489 | $31 |
2020: 4 services
| Return visit (30+ min) | 151 | $9,733 | $44 |
| Short return visit (20+ min) | 123 | $3,912 | $27 |
| New patient visit (45+ min) | 25 | $1,536 | $61 |
| Telephone medical discussion with physician, 11-20 minutes | 23 | $930 | $33 |
2019: 3 services
| Return visit (30+ min) | 124 | $7,783 | $49 |
| Short return visit (20+ min) | 105 | $3,695 | $32 |
| New patient visit (45+ min) | 11 | $826 | $75 |
2018: 2 services
| Short return visit (20+ min) | 38 | $2,937 | $49 |
| Return visit (30+ min) | 14 | $1,214 | $76 |
Drugs they prescribed that Part D paid
$590,731
Pharmacies billed $590,731 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (128 of 5,555) in 2024. Above the middle of the specialty; the typical physician assistant clinician is at 1%. Long-acting opioids: 10% of their opioid prescriptions.
4,701 generic and 823 brand-name prescriptions · $590,731 in drug cost · 73 antibiotic prescriptions to 50 people · 17 antipsychotic prescriptions to people over 65.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 85 | $89,627 | $1,054 |
| Ozempic | 69 | $86,683 | $1,256 |
| Jardiance | 51 | $73,050 | $1,432 |
| Mounjaro | 55 | $57,739 | $1,050 |
| Shingrix | 130 | $25,916 | $199 |
See all 98 drugs
| Eliquis | 85 | $89,627 | $1,054 |
| Ozempic | 69 | $86,683 | $1,256 |
| Jardiance | 51 | $73,050 | $1,432 |
| Mounjaro | 55 | $57,739 | $1,050 |
| Shingrix | 130 | $25,916 | $199 |
| Trelegy Ellipta | 15 | $16,288 | $1,086 |
| Farxiga | 21 | $13,389 | $638 |
| Abrysvo | 38 | $11,007 | $290 |
| Trulicity | 11 | $10,514 | $956 |
| Symbicort | 18 | $7,460 | $414 |
| Atorvastatin | 397 | $4,482 | $11 |
| Omeprazole | 170 | $3,362 | $20 |
| Lantus Solostar | 29 | $3,171 | $109 |
| Gabapentin | 128 | $2,478 | $19 |
| Duloxetine | 78 | $2,428 | $31 |
| Levothyroxine | 191 | $2,372 | $12 |
| Bupropion Xl | 68 | $1,962 | $29 |
| Amlodipine Besylate | 232 | $1,960 | $8 |
| Losartan | 186 | $1,952 | $10 |
| Pregabalin | 42 | $1,926 | $46 |
| Rosuvastatin | 172 | $1,825 | $11 |
| Telmisartan | 89 | $1,598 | $18 |
| Metoprolol | 121 | $1,580 | $13 |
| Boostrix Tdap | 28 | $1,496 | $53 |
| Metformin Hcl Er | 131 | $1,445 | $11 |
| Potassium Chloride | 85 | $1,311 | $15 |
| Celecoxib | 37 | $1,295 | $35 |
| Valsartan | 47 | $1,238 | $26 |
| Pantoprazole | 77 | $1,221 | $16 |
| Estradiol | 21 | $1,153 | $55 |
| Albuterol Sulfate Hfa | 37 | $1,083 | $29 |
| Memantine | 17 | $1,070 | $63 |
| Diltiazem 24hr Er (Cd) | 45 | $964 | $21 |
| Insulin Lispro Kwikpen U-100 | 11 | $948 | $86 |
| Venlafaxine Hcl Er | 30 | $930 | $31 |
| Hydrocodone-Acetaminophen | 51 | $925 | $18 |
| Candesartan Cilexetil | 15 | $869 | $58 |
| Carvedilol | 58 | $695 | $12 |
| Allopurinol | 60 | $692 | $12 |
| Alendronate | 105 | $641 | $6 |
| Escitalopram | 52 | $640 | $12 |
| Loperamide | 19 | $620 | $33 |
| Famotidine | 33 | $616 | $19 |
| Tamsulosin | 49 | $612 | $12 |
| Nitrofurantoin Mono-Macro | 21 | $581 | $28 |
| Trazodone | 63 | $575 | $9 |
| Meloxicam | 72 | $566 | $8 |
| Synthroid | 13 | $565 | $43 |
| Finasteride | 41 | $557 | $14 |
| Lisinopril | 75 | $534 | $7 |
| Spironolactone | 43 | $522 | $12 |
| Hydrochlorothiazide | 78 | $514 | $7 |
| Fluoxetine | 52 | $507 | $10 |
| Azelastine | 14 | $474 | $34 |
| Cyclobenzaprine | 44 | $442 | $10 |
| Tramadol | 57 | $439 | $8 |
| Olmesartan Medoxomil | 22 | $425 | $19 |
| Esomeprazole Magnesium | 11 | $417 | $38 |
| Sertraline | 44 | $413 | $9 |
| Bumetanide | 14 | $403 | $29 |
| Doxazosin Mesylate | 25 | $392 | $16 |
| Baclofen | 23 | $392 | $17 |
| Clopidogrel | 21 | $370 | $18 |
| Ondansetron Odt | 14 | $364 | $26 |
| Pravastatin | 27 | $360 | $13 |
| Fenofibrate | 11 | $357 | $32 |
| Fluticasone Propionate | 17 | $326 | $19 |
| Losartan-Hydrochlorothiazide | 25 | $321 | $13 |
| Montelukast | 35 | $321 | $9 |
| Nystatin | 20 | $317 | $16 |
| Simvastatin | 28 | $313 | $11 |
| Amitriptyline | 16 | $311 | $19 |
| Propranolol | 16 | $311 | $19 |
| Metoprolol | 43 | $310 | $7 |
| Diclofenac | 26 | $279 | $11 |
| Benazepril | 17 | $276 | $16 |
| Glipizide Er | 33 | $275 | $8 |
| Modafinil | 11 | $256 | $23 |
| Quetiapine | 12 | $231 | $19 |
| Pramipexole Dihydrochloride | 14 | $229 | $16 |
| Furosemide | 55 | $227 | $4 |
| Metformin | 48 | $208 | $4 |
| Donepezil | 18 | $205 | $11 |
| Triamterene-Hydrochlorothiazid | 24 | $199 | $8 |
| Warfarin | 21 | $188 | $9 |
| Pioglitazone | 16 | $177 | $11 |
| Ezetimibe | 11 | $177 | $16 |
| Clonidine | 12 | $161 | $13 |
| Dicyclomine | 14 | $154 | $11 |
| Aripiprazole | 11 | $145 | $13 |
| Atenolol | 30 | $130 | $4 |
| Lisinopril-Hydrochlorothiazide | 12 | $104 | $9 |
| Mupirocin | 14 | $98 | $7 |
| Buspirone | 14 | $84 | $6 |
| Primidone | 11 | $80 | $7 |
| Triamcinolone Acetonide | 17 | $64 | $4 |
| Citalopram Hbr | 17 | $54 | $3 |
| Telmisartan-Hydrochlorothiazid | 12 | $44 | $4 |
Year by year
| 2024 | 5,555 | 640 | 2% (128) | 15% | $590,731 |
| 2023 | 4,083 | 623 | 3% (108) | 12% | $514,790 |
| 2022 | 3,204 | 658 | 4% (117) | 13% | $365,448 |
| 2021 | 2,658 | 602 | 3% (76) | None | $206,133 |
| 2020 | 2,366 | 523 | 5% (110) | None | $162,013 |
| 2019 | 908 | 337 | 7% (63) | None | $61,926 |
| 2018 | 73 | 30 | None | None | $2,743 |
| 2017 | 195 | 68 | None | 13% | $10,878 |
| 2016 | 1,068 | 150 | 8% (82) | None | $53,056 |
| 2015 | 796 | 124 | 7% (55) | None | $47,496 |
| 2014 | 755 | 124 | 9% (64) | 17% | $30,044 |
| 2013 | 504 | 92 | 5% (26) | None | $25,620 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 82 drugs
| Eliquis | 65 | $85,040 | $1,308 |
| Ozempic | 52 | $73,094 | $1,406 |
| Jardiance | 22 | $37,197 | $1,691 |
| Mounjaro | 26 | $34,031 | $1,309 |
| Trulicity | 24 | $21,303 | $888 |
| Xarelto | 13 | $20,103 | $1,546 |
| Symbicort | 32 | $19,262 | $602 |
| Trelegy Ellipta | 19 | $18,649 | $982 |
| Lantus Solostar | 11 | $9,537 | $867 |
| Anoro Ellipta | 12 | $5,895 | $491 |
| Rosuvastatin | 97 | $5,004 | $52 |
| Atorvastatin | 308 | $4,716 | $15 |
| Losartan | 180 | $2,827 | $16 |
| Levothyroxine | 134 | $2,656 | $20 |
| Omeprazole | 139 | $2,500 | $18 |
| Gabapentin | 134 | $2,421 | $18 |
| Shingrix | 12 | $2,349 | $196 |
| Pregabalin | 30 | $2,175 | $73 |
| Duloxetine | 44 | $1,972 | $45 |
| Bupropion Xl | 53 | $1,808 | $34 |
| Metformin Hcl Er | 84 | $1,591 | $19 |
| Amlodipine Besylate | 149 | $1,273 | $9 |
| Metoprolol | 65 | $1,266 | $19 |
| Valsartan | 29 | $1,241 | $43 |
| Telmisartan | 19 | $1,220 | $64 |
| Celecoxib | 27 | $1,178 | $44 |
| Potassium Chloride | 51 | $1,177 | $23 |
| Allopurinol | 57 | $1,148 | $20 |
| Diltiazem 24hr Er (Cd) | 24 | $926 | $39 |
| Hydrocodone-Acetaminophen | 43 | $855 | $20 |
| Albuterol Sulfate Hfa | 25 | $842 | $34 |
| Tamsulosin | 35 | $836 | $24 |
| Pantoprazole | 52 | $806 | $15 |
| Carvedilol | 43 | $724 | $17 |
| Nitrofurantoin Mono-Macro | 17 | $716 | $42 |
| Triamterene-Hydrochlorothiazid | 41 | $706 | $17 |
| Fluoxetine | 47 | $698 | $15 |
| Terazosin | 19 | $695 | $37 |
| Diclofenac | 19 | $692 | $36 |
| Montelukast | 42 | $677 | $16 |
| Lisinopril | 85 | $666 | $8 |
| Losartan-Hydrochlorothiazide | 24 | $664 | $28 |
| Venlafaxine Hcl Er | 18 | $648 | $36 |
| Alendronate | 71 | $623 | $9 |
| Ropinirole | 14 | $583 | $42 |
| Trazodone | 37 | $581 | $16 |
| Doxazosin Mesylate | 20 | $562 | $28 |
| Pioglitazone | 22 | $538 | $24 |
| Escitalopram | 55 | $526 | $10 |
| Hydrochlorothiazide | 88 | $501 | $6 |
| Estradiol | 14 | $488 | $35 |
| Meloxicam | 58 | $479 | $8 |
| Clopidogrel | 25 | $465 | $19 |
| Furosemide | 65 | $458 | $7 |
| Metformin | 42 | $452 | $11 |
| Propranolol | 23 | $452 | $20 |
| Warfarin | 21 | $448 | $21 |
| Sertraline | 34 | $432 | $13 |
| Spironolactone | 32 | $406 | $13 |
| Finasteride | 21 | $403 | $19 |
| Simvastatin | 26 | $355 | $14 |
| Metoprolol | 16 | $332 | $21 |
| Famotidine | 13 | $319 | $25 |
| Paroxetine | 17 | $314 | $18 |
| Pravastatin | 11 | $304 | $28 |
| Fluticasone Propionate | 13 | $293 | $23 |
| Pramipexole Dihydrochloride | 12 | $293 | $24 |
| Atenolol | 22 | $254 | $12 |
| Amitriptyline | 11 | $249 | $23 |
| Quetiapine | 17 | $220 | $13 |
| Clonidine | 14 | $219 | $16 |
| Glipizide Er | 12 | $218 | $18 |
| Ondansetron Odt | 13 | $215 | $17 |
| Dicyclomine | 13 | $198 | $15 |
| Tramadol | 42 | $192 | $5 |
| Cephalexin | 11 | $177 | $16 |
| Lovastatin | 11 | $156 | $14 |
| Cyclobenzaprine | 25 | $143 | $6 |
| Baclofen | 13 | $134 | $10 |
| Paxlovid (Eua) | 11 | $118 | $11 |
| Mupirocin | 13 | $86 | $7 |
| Azithromycin | 11 | $30 | $3 |
2022: 62 drugs
| Eliquis | 107 | $111,538 | $1,042 |
| Jardiance | 17 | $23,170 | $1,363 |
| Xarelto | 15 | $19,307 | $1,287 |
| Trelegy Ellipta | 19 | $12,544 | $660 |
| Symbicort | 18 | $11,306 | $628 |
| Rosuvastatin | 64 | $3,150 | $49 |
| Atorvastatin | 195 | $2,956 | $15 |
| Omeprazole | 115 | $2,139 | $19 |
| Levothyroxine | 89 | $2,051 | $23 |
| Albuterol Sulfate Hfa | 49 | $1,890 | $39 |
| Gabapentin | 69 | $1,693 | $25 |
| Duloxetine | 29 | $1,672 | $58 |
| Metoprolol | 74 | $1,661 | $22 |
| Valsartan | 40 | $1,576 | $39 |
| Losartan | 139 | $1,408 | $10 |
| Bupropion Xl | 38 | $1,406 | $37 |
| Synthroid | 14 | $1,283 | $92 |
| Venlafaxine Hcl Er | 20 | $1,208 | $60 |
| Allopurinol | 50 | $1,068 | $21 |
| Pregabalin | 25 | $1,024 | $41 |
| Potassium Chloride | 43 | $987 | $23 |
| Alendronate | 59 | $957 | $16 |
| Amlodipine Besylate | 126 | $903 | $7 |
| Boostrix Tdap | 12 | $801 | $67 |
| Diclofenac | 29 | $786 | $27 |
| Estradiol | 11 | $770 | $70 |
| Hydrocodone-Acetaminophen | 50 | $728 | $15 |
| Valsartan-Hydrochlorothiazide | 14 | $726 | $52 |
| Triamterene-Hydrochlorothiazid | 31 | $694 | $22 |
| Celecoxib | 14 | $676 | $48 |
| Fluoxetine | 49 | $654 | $13 |
| Trazodone | 51 | $625 | $12 |
| Clopidogrel | 20 | $623 | $31 |
| Montelukast | 24 | $616 | $26 |
| Escitalopram | 41 | $590 | $14 |
| Meloxicam | 33 | $581 | $18 |
| Pantoprazole | 34 | $517 | $15 |
| Azelastine | 16 | $480 | $30 |
| Losartan-Hydrochlorothiazide | 23 | $476 | $21 |
| Diltiazem 24hr Er (Cd) | 11 | $475 | $43 |
| Carvedilol | 24 | $459 | $19 |
| Memantine | 12 | $432 | $36 |
| Lisinopril | 71 | $429 | $6 |
| Tamsulosin | 17 | $421 | $25 |
| Pravastatin | 23 | $420 | $18 |
| Hydrochlorothiazide | 58 | $390 | $7 |
| Simvastatin | 36 | $379 | $11 |
| Buspirone | 17 | $354 | $21 |
| Metformin Hcl Er | 43 | $330 | $8 |
| Warfarin | 16 | $279 | $17 |
| Finasteride | 12 | $278 | $23 |
| Sertraline | 29 | $272 | $9 |
| Furosemide | 36 | $263 | $7 |
| Doxazosin Mesylate | 12 | $253 | $21 |
| Famotidine | 14 | $233 | $17 |
| Tramadol | 51 | $228 | $4 |
| Cyclobenzaprine | 14 | $138 | $10 |
| Sulfamethoxazole-Trimethoprim | 19 | $131 | $7 |
| Mupirocin | 14 | $130 | $9 |
| Clonidine | 15 | $123 | $8 |
| Metformin | 24 | $122 | $5 |
| Paroxetine | 13 | $118 | $9 |
2021: 62 drugs
| Eliquis | 49 | $51,997 | $1,061 |
| Symbicort | 14 | $7,261 | $519 |
| Wixela Inhub | 11 | $2,619 | $238 |
| Omeprazole | 93 | $2,571 | $28 |
| Premarin | 12 | $2,567 | $214 |
| Potassium Chloride | 52 | $2,290 | $44 |
| Levothyroxine | 82 | $1,893 | $23 |
| Atorvastatin | 132 | $1,869 | $14 |
| Albuterol Sulfate Hfa | 38 | $1,746 | $46 |
| Gabapentin | 65 | $1,458 | $22 |
| Rosuvastatin | 29 | $1,405 | $48 |
| Diclofenac | 46 | $1,175 | $26 |
| Alendronate | 64 | $1,010 | $16 |
| Metoprolol | 38 | $975 | $26 |
| Losartan | 88 | $957 | $11 |
| Valsartan | 17 | $875 | $51 |
| Celecoxib | 11 | $855 | $78 |
| Duloxetine | 18 | $824 | $46 |
| Synthroid | 13 | $797 | $61 |
| Pregabalin | 15 | $742 | $49 |
| Ventolin Hfa | 11 | $703 | $64 |
| Allopurinol | 33 | $703 | $21 |
| Trazodone | 53 | $691 | $13 |
| Amlodipine Besylate | 94 | $633 | $7 |
| Pantoprazole | 27 | $608 | $23 |
| Azelastine | 28 | $577 | $21 |
| Diltiazem 24hr Er (Cd) | 14 | $577 | $41 |
| Bupropion Xl | 14 | $568 | $41 |
| Venlafaxine Hcl Er | 13 | $567 | $44 |
| Meloxicam | 47 | $532 | $11 |
| Hydrocodone-Acetaminophen | 29 | $529 | $18 |
| Losartan-Hydrochlorothiazide | 25 | $527 | $21 |
| Estradiol | 14 | $525 | $37 |
| Fluoxetine | 47 | $489 | $10 |
| Finasteride | 13 | $467 | $36 |
| Warfarin | 17 | $443 | $26 |
| Sertraline | 38 | $414 | $11 |
| Famotidine | 24 | $410 | $17 |
| Escitalopram | 32 | $390 | $12 |
| Triamterene-Hydrochlorothiazid | 19 | $375 | $20 |
| Pravastatin | 14 | $365 | $26 |
| Lisinopril | 53 | $353 | $7 |
| Clopidogrel | 15 | $310 | $21 |
| Buspirone | 23 | $303 | $13 |
| Metformin | 29 | $280 | $10 |
| Carvedilol | 19 | $277 | $15 |
| Quetiapine | 15 | $264 | $18 |
| Simvastatin | 26 | $246 | $9 |
| Furosemide | 45 | $246 | $5 |
| Mupirocin | 21 | $239 | $11 |
| Hydrochlorothiazide | 39 | $229 | $6 |
| Nystatin | 13 | $222 | $17 |
| Cyclobenzaprine | 19 | $204 | $11 |
| Montelukast | 16 | $198 | $12 |
| Tramadol | 36 | $159 | $4 |
| Metformin Hcl Er | 29 | $159 | $5 |
| Glimepiride | 14 | $100 | $7 |
| Zolpidem | 12 | $99 | $8 |
| Tamsulosin | 13 | $66 | $5 |
| Tizanidine | 11 | $63 | $6 |
| Triamcinolone Acetonide | 15 | $45 | $3 |
| Spironolactone | 17 | $44 | $3 |
2020: 57 drugs
| Eliquis | 30 | $31,348 | $1,045 |
| Trulicity | 11 | $16,071 | $1,461 |
| Symbicort | 16 | $9,010 | $563 |
| Lantus Solostar | 11 | $4,546 | $413 |
| Omeprazole | 86 | $1,720 | $20 |
| Gabapentin | 59 | $1,609 | $27 |
| Levothyroxine | 72 | $1,596 | $22 |
| Diclofenac | 32 | $1,588 | $50 |
| Memantine | 20 | $1,430 | $71 |
| Bupropion Xl | 24 | $1,369 | $57 |
| Losartan-Hydrochlorothiazide | 21 | $1,347 | $64 |
| Atorvastatin | 86 | $1,306 | $15 |
| Albuterol Sulfate Hfa | 18 | $1,033 | $57 |
| Losartan | 82 | $1,027 | $13 |
| Estradiol | 13 | $1,008 | $78 |
| Pregabalin | 11 | $982 | $89 |
| Montelukast | 45 | $856 | $19 |
| Hydrocodone-Acetaminophen | 61 | $840 | $14 |
| Trazodone | 59 | $833 | $14 |
| Allopurinol | 50 | $821 | $16 |
| Potassium Chloride | 25 | $807 | $32 |
| Ipratropium | 12 | $728 | $61 |
| Alendronate | 48 | $692 | $14 |
| Metoprolol | 38 | $674 | $18 |
| Chlorthalidone | 12 | $627 | $52 |
| Amlodipine Besylate | 91 | $587 | $6 |
| Clopidogrel | 22 | $563 | $26 |
| Fluoxetine | 37 | $562 | $15 |
| Escitalopram | 42 | $545 | $13 |
| Tamsulosin | 23 | $501 | $22 |
| Sucralfate | 15 | $400 | $27 |
| Lisinopril | 56 | $381 | $7 |
| Duloxetine | 11 | $371 | $34 |
| Pantoprazole | 19 | $352 | $19 |
| Finasteride | 15 | $342 | $23 |
| Sertraline | 22 | $308 | $14 |
| Warfarin | 19 | $306 | $16 |
| Spironolactone | 36 | $292 | $8 |
| Meloxicam | 36 | $287 | $8 |
| Ondansetron Odt | 15 | $266 | $18 |
| Nitrofurantoin Mono-Macro | 12 | $254 | $21 |
| Mupirocin | 24 | $253 | $11 |
| Pravastatin | 11 | $250 | $23 |
| Fluticasone Propionate | 13 | $247 | $19 |
| Tramadol | 38 | $224 | $6 |
| Hydrochlorothiazide | 31 | $220 | $7 |
| Rosuvastatin | 21 | $190 | $9 |
| Furosemide | 46 | $186 | $4 |
| Simvastatin | 23 | $186 | $8 |
| Buspirone | 22 | $167 | $8 |
| Metformin | 28 | $146 | $5 |
| Metformin Hcl Er | 17 | $146 | $9 |
| Cephalexin | 14 | $106 | $8 |
| Cyclobenzaprine | 14 | $97 | $7 |
| Lisinopril-Hydrochlorothiazide | 13 | $87 | $7 |
| Sulfamethoxazole-Trimethoprim | 17 | $70 | $4 |
| Triamcinolone Acetonide | 18 | $59 | $3 |
2019: 21 drugs
| Diclofenac | 27 | $919 | $34 |
| Gabapentin | 33 | $617 | $19 |
| Omeprazole | 21 | $545 | $26 |
| Hydrocodone-Acetaminophen | 33 | $543 | $16 |
| Doxycycline Hyclate | 18 | $491 | $27 |
| Atorvastatin | 23 | $444 | $19 |
| Escitalopram | 32 | $432 | $14 |
| Fluoxetine | 20 | $347 | $17 |
| Levothyroxine | 17 | $290 | $17 |
| Trazodone | 23 | $198 | $9 |
| Amlodipine Besylate | 28 | $195 | $7 |
| Lisinopril | 24 | $172 | $7 |
| Fluticasone Propionate | 12 | $165 | $14 |
| Losartan | 12 | $145 | $12 |
| Meloxicam | 13 | $143 | $11 |
| Triamcinolone Acetonide | 12 | $131 | $11 |
| Mupirocin | 11 | $128 | $12 |
| Hydrochlorothiazide | 13 | $127 | $10 |
| Tramadol | 19 | $81 | $4 |
| Furosemide | 13 | $65 | $5 |
| Zolpidem | 12 | $54 | $4 |
2018: 1 drug
| Atorvastatin | 11 | $113 | $10 |
2017: 4 drugs
| Levothyroxine | 15 | $465 | $31 |
| Atorvastatin | 13 | $235 | $18 |
| Losartan | 13 | $114 | $9 |
| Metoprolol | 11 | $76 | $7 |
2016: 25 drugs
| Zetia | 13 | $5,310 | $408 |
| Aspirin-Dipyridamole Er | 12 | $4,001 | $333 |
| Levothyroxine | 67 | $1,496 | $22 |
| Hydrocodone-Acetaminophen | 39 | $1,260 | $32 |
| Atorvastatin | 69 | $1,049 | $15 |
| Gabapentin | 76 | $935 | $12 |
| Duloxetine | 21 | $761 | $36 |
| Etodolac | 12 | $747 | $62 |
| Baclofen | 25 | $631 | $25 |
| Oxycodone-Acetaminophen | 12 | $440 | $37 |
| Losartan | 35 | $282 | $8 |
| Quetiapine | 12 | $272 | $23 |
| Tramadol | 12 | $260 | $22 |
| Metformin | 44 | $245 | $6 |
| Telmisartan | 12 | $242 | $20 |
| Trazodone | 30 | $212 | $7 |
| Amlodipine Besylate | 27 | $188 | $7 |
| Omeprazole | 19 | $185 | $10 |
| Lisinopril | 24 | $183 | $8 |
| Ibuprofen | 18 | $137 | $8 |
| Escitalopram | 13 | $114 | $9 |
| Metoprolol | 20 | $102 | $5 |
| Cyclobenzaprine | 12 | $93 | $8 |
| Hydrochlorothiazide | 13 | $48 | $4 |
| Simvastatin | 11 | $40 | $4 |
2015: 24 drugs
| Victoza 3-Pak | 12 | $7,898 | $658 |
| Advair Diskus | 13 | $5,180 | $398 |
| Duloxetine | 17 | $1,417 | $83 |
| Telmisartan | 12 | $1,051 | $88 |
| Hydrocodone-Acetaminophen | 26 | $923 | $36 |
| Gabapentin | 42 | $889 | $21 |
| Proair Hfa | 14 | $710 | $51 |
| Levothyroxine | 40 | $652 | $16 |
| Naltrexone | 14 | $570 | $41 |
| Doxepin | 13 | $379 | $29 |
| Allopurinol | 12 | $248 | $21 |
| Amlodipine Besylate | 34 | $220 | $6 |
| Trazodone | 19 | $190 | $10 |
| Montelukast | 12 | $189 | $16 |
| Atorvastatin | 13 | $185 | $14 |
| Metformin | 35 | $168 | $5 |
| Warfarin | 13 | $160 | $12 |
| Lisinopril | 16 | $148 | $9 |
| Losartan | 21 | $115 | $5 |
| Fluticasone Propionate | 12 | $98 | $8 |
| Paroxetine | 11 | $74 | $7 |
| Escitalopram | 13 | $63 | $5 |
| Simvastatin | 13 | $51 | $4 |
| Hydrochlorothiazide | 12 | $33 | $3 |
2014: 25 drugs
| Aggrenox | 13 | $4,070 | $313 |
| Duloxetine | 16 | $1,727 | $108 |
| Premarin | 17 | $1,677 | $99 |
| Proair Hfa | 13 | $737 | $57 |
| Gabapentin | 24 | $616 | $26 |
| Hydrocodone-Acetaminophen | 27 | $581 | $22 |
| Spironolactone | 14 | $540 | $39 |
| Carisoprodol | 12 | $531 | $44 |
| Bupropion Xl | 11 | $382 | $35 |
| Levothyroxine | 22 | $324 | $15 |
| Losartan | 34 | $288 | $8 |
| Doxepin | 13 | $243 | $19 |
| Warfarin | 27 | $233 | $9 |
| Trazodone | 17 | $188 | $11 |
| Paroxetine | 14 | $184 | $13 |
| Methadone | 16 | $180 | $11 |
| Escitalopram | 16 | $152 | $9 |
| Armour Thyroid | 11 | $143 | $13 |
| Metformin | 22 | $121 | $5 |
| Lisinopril | 16 | $101 | $6 |
| Hydrochlorothiazide | 27 | $97 | $4 |
| Alprazolam | 16 | $95 | $6 |
| Diazepam | 16 | $85 | $5 |
| Tramadol | 13 | $74 | $6 |
| Lisinopril-Hydrochlorothiazide | 18 | $72 | $4 |
2013: 12 drugs
| Advair Diskus | 16 | $5,663 | $354 |
| Lovastatin | 13 | $418 | $32 |
| Gabapentin | 12 | $313 | $26 |
| Triamcinolone Acetonide | 15 | $307 | $20 |
| Baclofen | 15 | $205 | $14 |
| Warfarin | 22 | $146 | $7 |
| Losartan | 14 | $144 | $10 |
| Metformin | 11 | $131 | $12 |
| Levothyroxine | 12 | $126 | $11 |
| Hydrochlorothiazide | 33 | $109 | $3 |
| Lisinopril-Hydrochlorothiazide | 15 | $100 | $7 |
| Metoprolol | 12 | $95 | $8 |
Money from drug and device companies
$44 in 2022
| 2022 | 1 | 2 | None | $44 |
| 2021 | 2 | 2 | None | $112 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Alkermes | Aristada | $44 | 2 payments
|
See all 2 published payments
| Alkermes | Meals · 2022-11-30 | Aristada | $20 |
| Alkermes | Meals · 2022-08-11 | Aristada | $24 |
See earlier years (2021)
2021: $112
| AstraZeneca Pharmaceuticals LP | Farxiga | $94 | 1 payment
|
| Alkermes | Aristada | $18 | 1 payment
|
Professional record
- NPI
- 1669742797
- Licence
- CA PA21972
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Physician assistant (363A00000X)
- Mailing address
- 221 E Hacienda Ave Ste B, Campbell, CA, 95008
- NPI first listed
- 2012-01-05
- NPI last updated
- 2017-10-29
This is when the NPI record was last certified, not a medical board exam.